Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Florida Pharmaceutical Products, LLC

NDC labeler codes: 69076, 71921

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

44Products (NDC)

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
April 6, 2026ANDA211156 Dapagliflozin
DAPAGLIFLOZIN
Inventia
February 23, 2026ANDA220385 Brivaracetam
BRIVARACETAM
Regcon Holdings
January 29, 2026ANDA220386 Lacosamide
LACOSAMIDE
Regcon Holdings
August 11, 2025ANDA218445 Rivaroxaban
RIVAROXABAN
Regcon Holdings
October 29, 2024ANDA219106 Varenicline tartrate
VARENICLINE TARTRATE
Regcon Holdings
August 20, 2024ANDA218613 Lofexidine hydrochloride
LOFEXIDINE HYDROCHLORIDE
Regcon Holdings
April 11, 2023ANDA216317 Valganciclovir
VALGANCICLOVIR HYDROCHLORIDE
Appco
March 23, 2023ANDA215086 Abiraterone acetate
ABIRATERONE ACETATE
Regcon Holdings
October 4, 2022ANDA201949 Brimonidine tartrate and timolol maleate
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Regcon Holdings
March 23, 2022ANDA215510 Aminocaproic acid
AMINOCAPROIC ACID
Regcon Holdings
March 17, 2022ANDA208308 Lacosamide
LACOSAMIDE
Regcon Holdings
February 17, 2021ANDA208967 Sumatriptan
SUMATRIPTAN
Regcon Holdings
July 28, 2020ANDA213474 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
Aiping Pharm Inc
April 13, 2020ANDA213547 Exemestane
EXEMESTANE
Qilu
December 9, 2019ANDA206045 Riluzole
RILUZOLE
Kenton
October 4, 2019ANDA206153 Rasagiline
RASAGILINE MESYLATE
Regcon Holdings
September 27, 2019ANDA212462 Abiraterone acetate
ABIRATERONE ACETATE
Qilu
March 2, 2018ANDA209498 Tenofovir disoproxil fumarate
TENOFOVIR DISOPROXIL FUMARATE
Qilu
July 28, 2016ANDA204467 Allopurinol
ALLOPURINOL
Regcon Holdings
November 18, 2014ANDA091691 Brimonidine tartrate
BRIMONIDINE TARTRATE
Regcon Holdings
September 11, 2014ANDA202053 Dorzolamide hydrochloride
DORZOLAMIDE HYDROCHLORIDE
Regcon Holdings
September 3, 2014ANDA202054 Dorzolamide hydrochloride and timolol maleate
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Regcon Holdings
February 3, 2014ANDA091182 Glycopyrrolate
GLYCOPYRROLATE
Regcon Holdings
April 17, 2013ANDA202112 Glimepiride
GLIMEPIRIDE
Regcon Holdings
January 26, 1999ANDA075090 Acyclovir
ACYCLOVIR
Regcon Holdings
October 15, 1986ANDA071268 Ibuprofen
IBUPROFEN
Contract Pharmacal
September 11, 1953NDA009053 Mercaptopurine
PURINETHOL
Stason Pharms

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

No recall of these products (by NDC code) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →